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Trachoma vaccine trials are being conducted by several laboratories  through- 
out the world. The degree  of antigenic variation within the causative agent(s) 
of tra~zhoma is crucial to the success of these vaccines. 
Strain differentiation  in trachoma was described  first by Dr. S. D. Bell,  Jr., 
and his associates  (1,  2).  These authors used active  immunity against toxic 
death in mice to delineate 16 of 19 strains into two groups. These in vivo stud- 
ies have been confirmed  by Chang el al.  (3), and Wang and Grayston (4). 
An in vitro technique for serologic  differentiation  of trachoma strains is de- 
scribed in this paper. Absorption of trachoma antiserum followed by fluorescent 
antibody  staining  of  individual  trachoma  strains  is  the  method  presented. 
Limitations of the test are emphasized. Changes in terminology are suggested 
to  facilitate  exactitude  as  insight  increases  into  the  biology  of  these  large 
viruses. 
TE]~OLOGY 
The descriptive terms "group antigen" and  "specific" or "strain-specific" antigen 
have been in use for many years. Group antigen indicated the heat-stable antigen held 
in common with all recognized members of the psittacosis,  lymphogranuloma vene- 
reum,  trachoma  (PLT)  viruses.  Specific  antigen,  found  to  be heat-labile,  usually 
implied  specificity  (5-8)  for  a  given  disease-producing  organism;  e.g.,  psittacosis, 
feline pneumonitis, etc. 
This terminology was adequate  until  recent  tests were  devised to exhibit  intra- 
disease antigenic  differences  among trachoma  and  inclusion  conjunctivitis  (TRIC) 
strains.  Bell  (1, 2) and Wang  (4)  divided the TRIC strain isolates into groups. Be- 
cause this use of "group antigen," in the intradisease (TKIC) sense, permits confusion 
with "group antigen" in the interdisease (PLT) meaning, minor changes in terminology 
are suggested. 
1.  C-m~up antigen will continue to indicate antigen held in common with the entire 
PLT group of organisms. To obviate all difficulties authors may wish to emphasize the 
scope of the antigen under question by the prefix PLT group antigen. 
* This work was conducted in part with support from the Arabian American Oil Company. 
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2.  It is suggested that the term specific be subdivided to express the authors' exact 
meaning as follows:  (a)  disease-specific antigen to imply feline pneumonitis-specific, 
trachoma-specific, etc. (b) type-specific antigen to indicate strains of organisms within 
a disease  entity which exhibit similar antigenic patterns to a given test, such as the 
mouse toxin test in trachoma. These may be categorized as types 1, 2, etc. The antigens 
in question are type-specific.  (c) strain-specific antigen to indicate an individual strain 
within a  given disease  showing considerable individuality, temporarily or  perma- 
nently resisting classification by  type.  Such waywardness may properly be termed 
strain specificity. 
Materials and Methods 
Virus Strain Deslgnation.l--A description of the strains of trachoma  virus employed in 
these studies has  been published  (2). The lymphogranuloma venereum (LGV) strain was 
LG-7, American Type Culture. Normal (non-infected) yolk sac is abbreviated NYS. 
Antigens.--Antigens were prepared from infected crude yolk sacs as previously described 
(9, 10). Absorbing and slide antigens were standardized by fourfold serial dilutions in M/15 
phosphate-buffered saline (PBS), pH 7.2-7.4, to extinction of specific immunofluorescence. 
The final dilution showing definite fluorescence was designated 1 unit of antigen. Repetition 
of the test under these conditions yielded standardizations which rarely varied more than one 
tube either way. 
Slide antigens were used at 160 or 320 units. Absorbing antigens were used at concentra- 
tions of 25 to 50 per cent yolk sac (64 to 4096 units as indicated in the tables). Four-hundred 
per cent concentrated and partially purified trachoma-absorbing antigens were occasionally 
used diluted in serum to a final concentration of 200 per cent. 
At times, to achieve the proper units for slide antigens or to standardize antigens, it was 
1 The  original designation  and  official nomenclature  for  the  trachoma  strains  are  re- 
spectively: 
SA-1  TRIC/  /SAU/HAR-1/OT 
SA-2  TRIC/  /SAU/HAR-2/OT 
SA-3  TRIC/  /SAU/HAR-3/OT 
SA-5  TRIC/  /SAU/HAR-S/OC 
SA-6  TRIC/  /SAU/HAR-6/OT 
SA-8  TRIC/  /SAU/HAR-8/OT 
SA-13  TRIC/  /SAU/HAR-16/OT 
EG-I  TRIC/  /ET/HAR-12/OT 
EG-II  TRIC/  /ET/HAR-13/OT 
ASGI-I  TRIC/  /USA-CAL/CAL-2/OT 
BOUR  TRIC/  /USA-CAL/CAL-1/OT 
A-7  TRIC/  /ETH/HAR-20/OT 
A-10  TRIC/  /ETH/HAR-22/OT 
P-2  TRIC/  /P/73-60,2/OT 
IlK  TRIC/  /I-IK/HAR-29/OT 
TW-1  (formerly  TW-10)  TRIC/  /TAIWAN/NAMRU  No. 2-1/OT 
LT-1  TRIC/  /GB/MRC-7/OT 
G-1  TRIC/  /WAG/MRC-1/OT 
TANG  TE-55 
Gear, J. I-I. S., Gordon, F. B., Jones, B. R., and Bell, S. D., Jr.,  Nomenclature of isolates of 
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necessary  to  dilute  infected  crude  yolk  sac  beyond  a 5  per  cent  suspension.  To  perceive  minimal 
amounts of fluorescing  antigen,  these  dilutions  were carried  out in S per cent  normal yolk 
sac, thus assuring a uniform background stain with Evans blue  ~ (9) against which the fluores- 
cence could be observed. 
Antigens have been divided into types i  and 2, derived from the group I  and II classifica- 
tion of Bell and Theobald (2). Based on the results of the present paper Tang and G-I strains 
have been placed in a non-classified  category. 
An~isera.--Blood  from a human volunteer (A. W.) vaccinated and infected (II) with SA-2 
strain trachoma was utilized for the major portion of this study.  Prior to  vaccination the 
complement fixation (CF) titer against group antigen was less than 1:5. At a  1:2 dilution but 
not at 1:8 this prevaccination serum produced specific immunofluorescence of LGV and Tang 
yolk sac antigens. No fluorescent staining of SA-2 or G-I trachoma strains was obtained from 
this prebleeding at a  1:2 dilution. After 3 injections of formalin-killed trachoma strain SA-2 
vaccine on days 0,  17, and  168, these titers remained unchanged.  Serum taken at the time 
of infectious challenge failed to stain any of the tested slide antigens after absorption. Fourteen 
days after infection with trachoma strain SA-2 both the CF and |mmunofuorescent antibody 
titers began to rise. Serum (termed hereafter serum i) obtained on the 39th postinfection day~ 
titered at  1:16 by immunofuorescence, proved useful in absorption.  Approximately 1 year 
later the titer had fallen to less than 1:2. The volunteer was revaccinated with strain SA-2 
trachoma vaccine. Nine days after vaccination serum (designated serum 2) was obtained with 
immunofuorescent titers varying between  1:4 and 1:8 for type 1 slide antigens, and  1:8 to 
1: 32 for both type 2 and the non-classified  antigens. This serum was utilized successfully for 
these  absorption studies. 
Rabbit trachoma antiserum (12),  prepared by repeated  intravenous  inoculation  of strain 
SA-2,  was kindly  supplied  by Mr. Peter  Reeve of  the  Lister  Institute  of  Preventive  Medicine, 
London. 
Method of Absorption and Staining.--Suspensionsof  infected Crude yolk sac, diluted as de- 
scribed above, were placed on glass slides with a  bacteriological loop. The plaques were ap- 
proximately 5 mm in diameter; up to 10 could be placed on an ordinary glass slide. Thin smears 
were prepared  for ease of reading.  After drying on the bench, slide antigens were fixed in 
acetone at 20-25°C for 10 minutes. At -20°C these slides could be stored for months, before 
or after acetone fixation, without materially affecting the staining properties. 
The serum to be absorbed was delivered by pipet into the bottom of a Kahn tube to avoid 
loss on the wall of the tube. Small amounts of serum were used but never less than 0.1 ml. An 
equal volume of absorbing antigen, suitably diluted, was added  at a  point just above the 
serum level. Mixture was by manual shaking. The serum-antigen mixture was incubated in 
a 37°C water bath for 60 minutes and left overnight at 4°C. During transfer from water bath 
to refrigerator the mixture was shaken vigorously. 
Additional mixing was done by pipet immediately before the serum-antigen mixture was 
placed on the slide antigen plaque. As little as 0.003 ml of material was necessary for adequate 
coverage of the antigen plaque. Following incubation at 37°C for 30 minutes, the slides were 
washed vigorously for 10 minutes in two changes of PBS. Five to six drops of Evans blue, 1 
per cent aqueous solution, were placed in this wash as a cotmterstain (9). The plaques were 
covered with fluorescein-conjugated anti-human  globulin obtained from several commercial 
sources,  incubated and washed as before. The slides were rinsed in distilled water,  dried,  and 
mounted with buffered glycerine, pH 7.2, under a coverslip. 
The optical system for immunofluorescence in use in our laboratory has been described (9) 
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RESULTS 
Absorption  of Human  Trachoma Antiserum.--Human  trachoma  antiserum 
was absorbed with 16 trachoma strains isolated from widely varying geographic 
areas.  An LGV strain was also used as absorbing antigen.  The absorption  pat- 
terns  (Table I) produced  with serum  2  proved  to be quite  reproducible  in re- 
peated  tests.  It was observed that: 
TABLE I 
A bsorptlon of Human Trachoma Antiserum (SA-2 Convalescent, Vaccine-Boostered) 
Trachoma-infected crude yolk sac-absorbing antigens* 
Slide antigens*  Type 1  Type 2  Non-classified 
Trachoma type 1 
SA-1,3,5,6,8..--~  -§-I]  + 
Egypt-I, II .....  I 
ASGH, A-10,  l 
P-2, H-K ..... 
Trachoma type 2  I 
SA-2,13 .......  +~+  +  +  +  +  +  '+  ',  + 
TW-   .........  +  :,  +  +  +  I++  !-  + 
BOUR ........  +  +  +:  +  +  +  --  + 
LT-I  ..........  +  +  +  +  "4-  "4-  "4-  "F  -f-  + 
A-7 ...........  +  +  A-  l+  +  +  +  ]+  I-4-  + 
Non-classified 
G-1 ...........  -  +  +  +  +  +  +  +  .......  + 
TANG ........  +  +  +  +  +  +  +  ~+  +  +  +  +  +  +  +¶-  .--  + 
LGV ..........  +  +  +  '+  +  +  +  +  +  +  +  +  +  +  +  + 
NYS ..........  [ 
* Slide antigens were standardized at 160 or 320 units (see text); absorbing antigens were 
used at the units shown at a final dilution of 50 or 25 per cent. Final dilution of antiserum 
was  1:2.  Data was assembled from repetitive tests of absorbing antigens;  thus absorption 
performed 3  times with antigens  SA-1,  and  SA-2,  2 times with  Eg-II, A-10,  G-l,  TW-1, 
LGV, Tang, Bout, and  1 time with the remainder. 
+, fluorescent staining of slide antigen after exposure to absorbed serum.  -,  no fluores- 
cent staining of slide antigen after exposure to absorbed serum. 
§ In successive tests this absorbed  serum yielded +  and  --  results when tested against 
ASGH, SA-2, Hour. 
H  In successive tests this absorbed  serum yielded +  and  --  results when tested against 
SA-3, SA-6, ASGH, P-2, H-K, LT-1. 
¶  In successive tests this absorbed  serum yielded +  and  -- results when tested against 
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I.  Homologous absorption was complete  in every instance as evidenced by 
failure of slide antigens to stain when exposed to serum absorbed with the same 
strain. 
2.  Absorption  of this antiserum with 8 trachoma strains from type I yielded 
serum which failed to react with type 1 slide antigens.  Repeated absorptions 
with these absorbing antigens produced 132 separate tests; in no instance was 
staining of type I antigen observed. The same absorbed  serum stained type 2 
slide antigens regularly; repetitive tests yielded 68 positive  stains in 84 tests 
of type 2 strains. Tang and LGV slide antigens were stained by this antiserum 
absorbed  with type I  strains. 
3.  Absorption  with type 2 antigens yielded antiserum which failed to react 
with type I and type 2 slide antigens.  In a total of 216 tests type 2-absorbed 
serum produced staining only 6 times, in each instance of type 2 slide antigens. 
Subsequent tests failed to confirm these 6 positive stains and they were judged 
aberrant. Serum absorbed  with type 2 antigens reacted with Tang and LGV 
strains but failed to stain G-I. 
4.  G-I slide antigen reacted to serum 2, absorbed with various antigens, in a 
manner slmilar to the type 2 strains. However,  SA-I  absorbed  antiserum did 
not stain G-I, and G-I  absorbed  serum reacted irregularly with Tang slide 
antigen. These two discrepancies made it advisable to place G-I in an unclassi- 
fied category. 
5.  Absorption  of this human trachoma antiserum with Tang and LGV anti- 
gens produced rather irregular  staining in both types I  and 2 slide antigens. 
The interlocking relationships  of these isolates,--Tang and LGV,--were strik- 
ing. No absorbing  antigen removed antibody to the Tang strain except Tang 
itself.  LGV, and G-I  (the latter irregularly).  No absorbing  antigen removed 
antibody to the LGV strain except LGV itself and Tang. It was concluded that 
Tang (TE-5S)  and this strain of LGV were quite s{mHar antigenically. 
Absorption  of rabbit trachoma (SA-2) antiserum with these same antigens 
gave preliminary results which appeared to substantiate the difference between 
types I  and 2 slide antigens demonstrated with human trachoma antiserum. 
Additional trials with animal antiserum will be undertaken when adequate 
amounts of serum can be obtained. 
Controls and E~ence for Specificity.--Controls  and evidence for specificity 
which are applicable to all data recorded in this paper are summarized: 
1.  All tests were read and recorded while the microscopist was unaware of 
the strain of antigen present on the slide and/or the antigen used for absorbing 
the antiserum. 
2.  Normal yolk sac controls were always included; i.e., the serum under test 
was always absorbed  with normal yolk sac and normal yolk sac was always 
present as a slide "antigen." 
3.  The anti-human globlllln conjugate failed to stain any of the slide antigens 
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4.  Slide  antigens were diluted to find the optimum concentration of virus 
permitting maximum intensity of stain with a weak antiserum. Dilutions tested 
ranged from 10 per cent in twofold dilutions down to 0.08 per cent. Slide anti- 
gens were easily visible at all concentrations. In consequence, slide antigens 
were standardized at 160 or 320 units in suspensions varying from 0.3  to 10 
per cent crude infected yolk sac. 
5.  Absorbing antigens were not "standardized" in the sense that equal con  ,- 
centrations of virus were used with each strain for absorption. The variation in 
the amount of virus in available yolk sac pools precluded such standardization. 
However, the concentration of virus per unit volume in the individual strains 
of absorbing antigens could be ascertained and is expressed in units in Table I. 
These unitages vary from 64 to 4096.  Complete homologous absorption was 
obtained at both extremes of unitage and at each unit level between these two 
extremes. It was assumed,  therefore, that absorbing antigen was present in 
considerable excess and that the variation in concentration of absorbing anti- 
gens would withstand scrutiny. 
6.  Absorption with crude yolk sac antigens was compared with parallel ab- 
sorptions of 400 per cent concentrated and partially purified antigens (2) from 
the same strain. Using 6 strains of absorbing antigens and 20 strains of slide 
antigens, results of the crude and purified absorbing antigens were identical 
in 74 of 85 instances. It was concluded that the purification and concentration 
procedure did not alter this test. 
7. In the technique described in this paper, the products of the absorption 
reaction were not removed prior to overlaying the slide antigen with the serum- 
antigen mixture. To test the thesis that these products might in some way in- 
fluence the results, they were removed. Two methods to effect removal were 
employed. The first involved a  slow-speed centrifugation (1500 m,x¢, 10 min- 
utes, 0-4°C)  after which the supernatant was spun in a  model L  Spinco at 
high-speed (rotor No.  21, 20,000 RPM, 30 minutes, 0-4°C). The middle layer 
from this high-speed centrifugation was carefully removed with a  fine pipet 
and tested as an absorbed antiserum or exposed a  second time to absorbing 
antigen and centrifuged as before. 
The second method for removing the products of the absorption reaction was 
to filter the antigen-antiserum mixture through a 5.0/~ Millipore filter followed 
by high-speed centrifugation as above. Whether absorbed once or twice, with 
products of the absorption reaction removed or not, the staining of the slide 
antigens was not materially affected. After removal of the absorption products 
only 16 of 218 readings were changed, in each case from positive to negative. 
It was concluded that products of the antigen-antibody reaction present in 
the mixture overlying the slide antigen did not affect the outcome of the test. 
8.  Dissociation of the antigen-antibody complex under conditions of the test 
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antigen-antiserum  mixture was then placed at 4°C for 6 days and  the slide 
antigens again stained. At the end of this period no difference in staining of slide 
antigens  was observed. Antigen-antibody  dissociation  was not  a  significant 
factor in this technique. 
9.  Dilution of the absorbing antigen in 100 per cent normal yolk sac, instead 
of PBS, followed by centrifugation as before, changed only 3 of 21 readings 
from positive to negative. 
10.  Absorbing and slide antigen controls composed of normal yolk sac were 
included in each test. In addition normal yolk sac, used for absorption, was 
removed by centrifugation as described above, prior to application to the slide 
antigen.  No change in the pattern of staining was observed after these pro- 
cedures, 
11.  No immunofluorescence  (Fig.  1) of SA-2 slide antigen was visible after 
homologous absorption of human trachoma antiserum 2. A bright fluorescent 
stain  (Fig.  2) of SA-2 slide antigen was seen after heterologous absorption of 
the same serum with SA-1 trachoma strain. 
Quantitative Absorption Studies.--The type specificity noted in Table I may 
have been due to qualitative or quantitative variation of antigenic pattern in 
the trachoma virus strains.  To investigate this,  antigens were used in serial 
dilutions for absorption of the same serum. Text-fig.  1 graphically illustrates 
the immunofluorescent pattern  derived from absorption of human  trachoma 
antiserum 2 with progressively diminishing  amounts of SA-1 antigen. The black 
areas indicate positive fluorescent stain and hence incomplete absorption. All 
type 1 slide antigens showed immunofluorescence  when exposed to antiserum 
absorbed with 64 units of SA-1 antigen. The majority of these antigens failed 
to stain with antiserum absorbed with 128 units of antigen. In contrast, type 2 
slide antigens continued to fluoresce after exposure to antiserum absorbed with 
1024 units of SA-1 antigen. 
This technique permitted an assessment of the variation in antigenic com- 
position found in  types 1 and  2 slide  antigens.  Approximately a  tenfold in- 
crease in  absorbing antigen  was required  to remove antibody reactive with 
type 2 as compared with type 1 slide antigens. 
Text-fig.  2 depicts the same antiserum absorbed with diminishing  amounts 
of SA-2 antigen.  As in Table I, type 2-absorbing antigen removed antibody 
reactive both to types 1 and 2 with the exception of strain Bout. The failure 
of Egypt II slide antigen to stain is striking; no immunofluorescence  was seen 
until only 4 units of absorbing antigen were used. Tang,  G-l, and LGV con- 
tinued to react with antiserum absorbed with the maximum unitage of antigen. 
Text-figs.  1 and 2 were derived from the same antiserum used in Table I 
and may be compared with that table at the appropriate unitage of absorbing 
antigen. 
Text-fig.  3  is  a  similar  study using  SA-2  absorbing  antigen  and  human I 
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trachoma  antiserum  1.  Twofold dilutions  of absorbing  antigens  were  used 
from 6400 through 400 units; thereafter fourfold dilutions were employed. Tang 
and LGV were the only two slide antigens which continued to stain with anti- 
serum absorbed with 6400 units.  This observation, together with that noted 
in Text-fig.  2, strengthens the evidence for relationship between the Tang and 
LGV strains first remarked in Table I  above. 
Egypt II slide antigen failed to stain when exposed to antiserum absorbed 
with the least amount of antigen used; i.e., 0.1 per cent suspension (6.25 units). 
This individuality of Egypt II served to confirm  the antigenic irregularity of 
this strain noted in Text-fig.  2. The failure of Egypt I to stain was unexpected. 
TABLE II 
Effect of Heated Antigens* on Trachoma Group Absorption Patterns~ 
Absorbing 
&ntigens 
Type 1 
Type 2 
Slide 
antigens 
Type 1 
Type 2 
Type 1 
Type 2 
Control  Heated slide 
(unheated)  antigens 
-§  + 
+§  + 
-  + 
-  + 
Heated absorbing 
Irregularl] 
Irregular 
Heated slide and 
absorbing antigens 
Irregular 
+ 
Irregular 
Irregular 
*:Slide: and 'or absorbing  antigens heated to 60°C for 60 minutes as indicated. 
:~ Abso~tion of human trachoma antiserum 2 (SA-2 convalescent, vaccine-boostered). 
§ -  no immunofluorescent stain of slide antigens by serum absorbed as indicated; -~, 
presence of immtm0fluoreseent stain of slide antigens by serum absorbed as indicated. 
l] Irreguhr indicates both -]-:  and -- results were Observed. 
A  discussion of possible causes for the variations  observed in Text-fig.  2 
revsu~ Text-fig.  3is presented below. 
Effect of Heat.--Slide antigens, absorbing antigens, or both were heated to 
60°C for 60 minutes in a water bath prior to use. Antigens and antiserum were 
identical with those used in Table I. The results are shown in Table II. 
Unheated controls yielded an absorption pattern entirely analogous to that 
of Table I. Heating the slide antigens led to an abrupt change.  When heated, 
all slide  antigens stained regardless  of the absorbing antigen.  Moreover, the 
brilliance  of the stain was enhanced markedly. 
Heating the absorbing antigens produced irregular  staining in type 2 slide 
antigens. When both slide and absorbing antigens were heated, irregular stain 
was created in 3 of the 4 categories. 
Because the slide and absorbing antigens were crude yolk sac, boiling  tem- 
peratures coagulated the yolk sac and prevented accurate dilutions.  Such at- 
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DISCUSSION 
These experiments appear to permit serologic strain differentiation of tra- 
~choma isolates. However, the limitations of the method must be emphasized. 
The technique is restricted in practice by the scarcity of antisera of suitable 
titer and homogeneity. And a limitation in theory is imposed by lack of criteria 
to assess  the relevancy of perceived antigenic differences to the problems of 
vaccine eflficacy in field trials. 
The practical limitations are several in number. Early in the development 
,of this work it was apparent that many of the anfisera available for testing 
could not be absorbed successfully. Sera with titers of 1: 8 or less usually failed 
to stain  after absorption.  Human antisera from vaccinated patients,  though 
titered 1:32 or more by CF and fluorescent antibody, yielded inconsistent re- 
sults.  Mter  absorption  these postvaccination sera  frequently failed to  stain 
any of the  trachoma slide  antigens.  Following challenge and infection with 
Srachoma, antiserum which could be utilized was obtained from a vaccinated 
volunteer. The antibody titer of this convalescent serum was not higher than 
titers found in postvaccination sera discussed above. 
Attempts to produce suitable antisera in animals have not been successful 
in our laboratory. These studies have been handicapped by lack of antiserum 
to type 1 strains of trachoma virus. 
Before vaccination or infection with a trachoma agent, screening of sera from 
animals  or humans used in these studies frequently revealed the presence of 
PLT group antibody in low titer to one or more of the antigens under test. 
Failure to find antibodies was not considered sufficient evidence to warrant the 
assumption  that  a  monovalent antibody response in  humans  or in  animals 
would be evoked by vaccination or infection with a trachoma agent. The PLT 
agents, notoriously poor antibody producers (13), may elicit a temporary anti- 
body response; subsequent stimulation with trachoma antigen of a  subject in 
which no PLT antibodies are detectable may then produce an anamnestic re- 
sponse which yields an antibody population of moderate to gross heterogeneity. 
In these series of experiments it is doubtful if any of the sera studied con- 
rained only a  single species of antibody to a  given strain of trachoma. Some 
variability of the results of absorptions in sera from varying sources was  ex- 
pected and found. With a given antiserum the results were consistent and re- 
producible. 
Heterogeneity of the antigens, as well as of the antibody population, could 
be expected to affect the reproducibility of the results. There is little assurance 
that a designated trachoma strain contains, in fact, only one serologically dis- 
tinct population of virus. Mixed infections may exist in the eye and be rep- 
resented  in  the  original  isolates.  Laboratory contamination may intrude  to 
destroy the homogeneity of a  given strain.  Mutation or selective passage  in 
eggs may alter the growth and virulence characteristics of the virus (12) with 
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The fluorescent antibody test, as described in this paper, necessitates a  sub- 
jective evaluation.  Experience is required  to recognize minimal degrees of im- 
mtmofluorescence  of various  PLT  strains.  Each  strain  stains  somewhat  dif- 
ferently. Nevertheless, with experience nearly identical readings can be obtained 
by microscopists working independently.  Correlation of repetitive  tests in the 
opinion of the authors is excellent for a  serologic technique. 
The limitations in theory are more formidable. When attempting to approach im- 
munologic specificity,  the heterogeneity of the antibody population constitutes  the 
most  important  obstacle.  Burnet  has  stated  (14)  and  reaffirmed  (15)  that,  with 
bacteria at least, there is no evidence for the presence of a mosaic of antigens on the 
bacterial surface; the evidence is for diversity in the antibody population, not in the 
antigen population. The assumption is that any antigenic molecule carries a variety 
of potential  antigenic  determinants,  but  that  any antiserum  will  contain antibody 
molecules carrying complementary groupings not representative of the whole antigen. 
Burnet points out that  the  system concerned with antibody production, i.e. the 
virus particle presumably in the process of disintegration in the antibody-producing 
cells of the host, is different from the virus particle with which the antiserum reacts 
in an experimental test (15). Thus it was reasonable that Hirst (16), using influenza A 
virus to absorb immune sera,  should find both large and small antigenic differences 
even with strains isolated in the same epidemic. He postulated an infinite  variety of 
antigenic patterns with exceedingly complex interrelationships, a view fortified by the 
somewhat conflicting attempts at compression of influenza A strains into broad groups. 
A similar situation may pertain to the trachoma strains under study. Bedson, in his 
classic monograph on the  antigenic  composition of psittacosis  virus,  first  reported 
enhancement of antigenic activity by heating and still further improvement by boiling 
of psittacosis elementary body suspensions.  Bedson concluded that heating probably 
destroyed something on the surface of the virus bodies and so unmasked the PLT 
group antigen which was heat-stable (5). 
After 27 years, this observation by Bedson on the role of heat in altering the anti- 
genicity of PLT viruses remains empiric. No rational explanation has supervened to 
open new insights into the phenomenon of antigenic enhancement in the PLT group 
by boiling. In the present example temperatures were limited to 60°C. Yet the results 
were clear-cut. Before heating, in 3 of the 4 categories no antigen-antibody reaction 
took place in sufficient degree to permit an observable stain.  After the slide antigens 
were heated, a brilliant stain in all 4 categories was apparent.  The antigen-antiserum 
mixture was unchanged; 60°C heat had effected a marked change in the slide antigen, 
altering or uncovering the antigens  in  some unknown way to permit  a  reaction  to 
Occur. 
Burnet's postulate  of antibody heterogeneity  seems applicable  to this  experiment. 
Antibody incapable  of reacting  with unheated slide  antigens  was present  in this  anti- 
serum after  absorption  with various antigens;  heat-altered  antigen reacted with this 
antibody producing a brilliant  stain. 
Setting aside the practical and theoretical limitations, several advantages 
of this  method  are obvious. In other types of serologic tests to increase the 
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the products of the reaction must be removed, usually by centrifugation or 
filtration. It is an advantage of the immunofluorescent technique that this step 
is obviated, for the antigen of the indicating reaction is fixed to the slide. The 
products of the absorbing reaction are removed by the usual washing procedures 
and do not interfere with the reading of the experimental results. Furthermore, 
the volume of reagents needed is small so that little absorbing antigen is re- 
quired. 
The degree of antigenic variation, noted to be greater with the first of the 
two antisera obtained from the human volunteer, may be significant. It ap- 
pears that the first serum (Text-fig. 3) is more sensitive to antigenic differences 
in the slide antigens than is the second serum (Text-fig. 2). This may be due 
to a gradual broadening in the specificity of the antibody response with time, 
or to a decrease in specificity induced by the vaccine booster, or both. 
Whether the  type-specific antigenic variation described in this paper  rep- 
resents a qualitative or a quantitative difference between strains merits serious 
consideration. A significant quantitative variation in the antigens of trachoma 
strains types 1 and 2 is apparent in the results presented. The antiserum used 
was of low titer,  1:4 to 1:32 depending upon the trachoma strains tested. A 
tenfold increase in absorbing antigen, applied to this low titered antiserum, 
was insufficient to eliminate the antigenic disparity. Repeated absorptions, up 
to the point of exhaustion of the antiserum, also failed to delete the antigenic 
variation between trachoma slide antigens of type 1 versus type 2. In the opin- 
ion of the authors a divergence of this magnitude is compatible with, but does 
not prove, a qualitative difference in the antigenic structure of the two types 
of trachoma strain isolates. A more critical analysis must await the availability 
of trachoma antiserum of relative homogeneity and high titer. 
From this study of 19 trachoma virus strains one gains the impression of 
antigenic patterns with complex interrelationships. However, for purposes of 
vaccination of patients the antigenic variation per se is unimportant; rather, 
the immunologic heterogeneity as it pertains to an antitoxic or an antiinfective 
vaccine should concern us. Minor or major disparities in antigen structure, as 
revealed by a  given CF, agglutination, or serum absorption test such as de- 
scribed in this paper, may have no bearing on the immunological protection 
afforded a patient by a vaccine. At this juncture, a relation between serologic 
test and vaccine efficacy can be verified only in a field vaccine trial. 
Type- and strain-specific relationships in the trachoma isolates studied have 
been demonstrated by the in vitro technique described in this paper. The prac- 
tical significance of these findings remains to be explored. 
S~ARY 
An in  vitro test for the differentiation of trachoma strain isolates was de- 
scribed. The method was based on absorption of trachoma antiserum followed 
by immunofluorescent stainlug of individual trachoma strains. ROGER  L. NICHOLS  AND  DOROTHY  E. ~rcCOM~  653 
Nineteen trachoma strains  were  studied;  two main  types were identified. 
Evidence for quantitative and qualitative antigenic variation between the two 
types was presented. The limitations in practice and in theory of the test were 
emphasized. 
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EXPLANATION OF PLATE 67 
FIG. 1.  Failure of SA-2 trachoma strain to fluoresce  after homologous absorption; 
details in text.  X 320. 
FIG. 2.  Immunofluorescence of SA-2 trachoma strain after heterologous absorption; 
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